Novogene Technology's competitors

Novogene Technology's competitors include Cord Blood America, Synthace, International Stem Cell Corporation and InVitae
Add company...
Novogene Technology
Providing advanced genomic solution
Cord Blood America
Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.
Synthace
Synthace produces bio-based chemical products through the application of synthetic biology.
International Stem Cell Corporation
International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.
InVitae
InVitae provides genetic diagnostics for hereditary disorders.
Founding Date
Founding Date
2011
Founding Date
1999
Founding Date
2011
Founding Date
2001
Founding Date
2010
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Chula Vista, US HQ
Wuqing, CN
Haidian Qu, CN
Hong Kong, HK
Naka Ku, JP
Midori Ward, JP
Seri Kembangan, MY
see more
Locations
Las Vegas, US HQ
Locations
London, GB HQ
Locations
Carlsbad, US HQ
Locations
San Francisco, US HQ
Employees
Employees
3242% increase
Employees
15
Employees
405% increase
Employees
41
Employees
50940% increase
Valuation ($)
Valuation ($)
N/A
Valuation ($)
3.7 m
Valuation ($)
N/A
Valuation ($)
6.7 m
Valuation ($)
486.6 m
Facebook likes
Facebook likes
35
Facebook likes
N/A
Facebook likes
66
Facebook likes
3.8 k
Facebook likes
23.5 k
Twitter followers
Twitter followers
33
Twitter followers
N/A
Twitter followers
506
Twitter followers
10.1 k
Twitter followers
5.3 k

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$3.3m (FY, 2016)
Revenue (est.)
£581 (FY, 2013)
Revenue (est.)
$7.2b (FY, 2016)
Revenue (est.)
$68.2m (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
$904.9k (FY, 2016)
Cost of goods
N/A
Cost of goods
$1.9b (FY, 2016)
Cost of goods
N/A
Gross profit
Gross profit
N/A
Gross profit
$2.4m (FY, 2016)
Gross profit
N/A
Gross profit
$5.2b (FY, 2016)
Gross profit
N/A
Net income
Net income
N/A
Net income
$102.2k (FY, 2016)
Net income
(£361.6k) (FY, 2013)
Net income
($1.1b) (FY, 2016)
Net income
($123.4m) (FY, 2017)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 16.2m
Total funding raised
$ 2.5m
Total funding raised
$ 195.5m
For sources of this data, please see the company profileDownload Excel

View company profiles

Cord Blood America
HQ
Las Vegas, US
Employees
15

Cord Blood America, Inc. provides cord blood and cord tissue stem cell services.

View company
Synthace
HQ
London, GB
Employees
40↑ 5% increase

Synthace produces bio-based chemical products through the application of synthetic biology.

View company
International Stem Cell Corporation
HQ
Carlsbad, US
Employees
41

International Stem Cell Corporation is a California-based biotechnology company focused on therapeutic and research products.

View company
InVitae
HQ
San Francisco, US
Employees
509↑ 40% increase

InVitae provides genetic diagnostics for hereditary disorders.

View company